Task: Answer the multiple choice question.
Query: Which drug exhibits a -3.733% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a.) COCCNC(=O)c1cc2c(-c3ccccc3F)nn(C)c2s1
b.) CC(C)SCc1nc2ccccc2[nH]1
c.) O=C1c2ccccc2NC(c2ccc(Br)s2)N1O
d.) CCC(=O)Nc1ccccc1C(=O)N1CCCC1
Answer: b. CC(C)SCc1nc2ccccc2[nH]1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)SCc1nc2ccccc2[nH]1
CC(C)SCc1nc2ccccc2[nH]1
2-(propan-2-ylsulfanylmethyl)-1H-benzimidazole